KURA
Kura Oncology Inc
NASDAQ: KURA · HEALTHCARE · BIOTECHNOLOGY
$8.75
-0.91% today
Updated 2026-04-29
Market cap
$776.67M
P/E ratio
—
P/S ratio
11.51x
EPS (TTM)
$-3.18
Dividend yield
—
52W range
$5 – $12
Volume
1.5M
Kura Oncology Inc (KURA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-76.6%
Last 4 quarters
Revenue YoY growth
-67.8%
Most recent quarter
EPS YoY growth
-318.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.5%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-8.1%
2025-08-07
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-05 | $-0.92 | -253.7% | $8.55 | $8.96 | +4.8% |
| 2025-11-04 | $-0.85 | -13.3% | $9.77 | $9.94 | +1.7% |
| 2025-08-07 | $-0.75 | -82.9% | $6.03 | $5.54 | -8.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.26 | $-0.92 | -253.7% | $17.34M | -67.8% |
| 2025-09-30 | $-0.75 | $-0.85 | -13.3% | $20.75M | — |
| 2025-06-30 | $-0.41 | $-0.75 | -82.9% | $15.29M | — |
| 2025-03-31 | $-0.60 | $-0.66 | -10.0% | $14.11M | — |
| 2024-12-31 | $-0.64 | $-0.22 | +65.5% | $53.88M | +4142.8% |
| 2024-09-30 | $-0.63 | $-0.63 | +0.0% | — | — |
| 2024-06-30 | $-0.63 | $-0.59 | +6.3% | — | — |
| 2024-03-31 | $-0.55 | $-0.59 | -7.3% | — | — |
| 2023-12-31 | $-0.55 | $-0.55 | +0.0% | $1.27M | — |
| 2023-09-30 | $-0.55 | $-0.50 | +9.1% | — | — |
| 2023-06-30 | $-0.55 | $-0.53 | +3.6% | — | — |
Frequently asked questions
Has Kura Oncology Inc beaten earnings estimates?
Kura Oncology Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -76.6% over the last 4 quarters.
How does KURA stock react to earnings?
KURA stock has moved an average of -0.5% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Kura Oncology Inc's revenue growth rate?
Kura Oncology Inc reported year-over-year revenue growth of -67.8% in its most recent quarter, with EPS growing -318.2% year-over-year.